The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 11, 2022
Filed:
Sep. 08, 2017
Applicant:
C.r. Bard, Inc., Murray Hill, NJ (US);
Inventor:
Hiep Do, Chandler, AZ (US);
Assignee:
C. R. BARD, INC., Murray Hill, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 39/02 (2006.01); A61M 25/10 (2013.01); A61M 1/36 (2006.01); A61M 1/14 (2006.01); A61L 31/00 (2006.01); A61B 17/12 (2006.01);
U.S. Cl.
CPC ...
A61M 39/0247 (2013.01); A61M 1/14 (2013.01); A61M 1/3655 (2013.01); A61M 25/104 (2013.01); A61M 25/1011 (2013.01); A61B 17/12045 (2013.01); A61B 17/12109 (2013.01); A61B 17/12136 (2013.01); A61L 31/00 (2013.01); A61M 2025/1052 (2013.01); A61M 2039/0258 (2013.01); A61M 2039/0261 (2013.01); A61M 2039/0276 (2013.01); A61M 2039/0291 (2013.01); A61M 2039/0297 (2013.01);
Abstract
A method and apparatus are aimed to improve arteriovenous fistula maturation rate by treating the fistula with a crosslink agent solution (fixative solution). The fixative solution will crosslink proteins and biomolecules, allowing formation of crosslinks that stabilize or stable tissue structure. The method and apparatus will address factors that contribute to arteriovenous fistula maturation failure by stopping the neointimal hyperplasia growth after vascular injury and stabilizing the venous wall to prevent the lumen from narrowing.